Results     31-May-23
Announcements
Marksans Pharma consolidated net profit rises 191.46% in the March 2023 quarter
Sales rise 16.25% to Rs 485.98 crore
Net profit of Marksans Pharma rose 191.46% to Rs 81.93 crore in the quarter ended March 2023 as against Rs 28.11 crore during the previous quarter ended March 2022. Sales rose 16.25% to Rs 485.98 crore in the quarter ended March 2023 as against Rs 418.04 crore during the previous quarter ended March 2022.

For the full year,net profit rose 44.29% to Rs 266.31 crore in the year ended March 2023 as against Rs 184.57 crore during the previous year ended March 2022. Sales rose 24.23% to Rs 1852.14 crore in the year ended March 2023 as against Rs 1490.84 crore during the previous year ended March 2022.

ParticularsQuarter EndedYear Ended
 Mar. 2023Mar. 2022% Var.Mar. 2023Mar. 2022% Var.
Sales485.98418.04 16 1852.141490.84 24
OPM %22.5415.22 -18.3217.36 -
PBDT118.1273.96 60 389.51292.29 33
PBT104.1752.60 98 337.65247.51 36
NP81.9328.11 191 266.31184.57 44

Previous News
  Marksans Pharma consolidated net profit declines 4.44% in the March 2024 quarter
 ( Results - Announcements 30-May-24   12:46 )
  Marksans Pharma announces receipt of UKMHRA approval for Fluoxetine capsules
 ( Corporate News - 21-Aug-24   20:00 )
  Marksans Pharma standalone net profit rises 45.76% in the September 2022 quarter
 ( Results - Announcements 15-Nov-22   08:41 )
  Marksans Pharma to declare Quarterly Result
 ( Corporate News - 17-Jan-24   17:29 )
  Marksans Pharma surges after Q1 PAT rises 29% YoY to Rs 89 cr
 ( Hot Pursuit - 14-Aug-24   12:04 )
  Marksans Pharma gains on receiving USFDA approval for Guaifenesin tablets
 ( Hot Pursuit - 22-Aug-23   14:54 )
  Board of Marksans Pharma recommends final dividend
 ( Corporate News - 31-May-23   12:46 )
  Marksans Pharma to conduct board meeting
 ( Corporate News - 03-Feb-23   18:58 )
  Marksans Pharma commences buyback of shares
 ( Corporate News - 15-Jul-22   17:50 )
  Marksans Pharma to conduct board meeting
 ( Corporate News - 11-Jan-23   15:37 )
  Board of Marksans Pharma allots convertible warrants
 ( Corporate News - 23-Jul-21   14:32 )
Other Stories
  Shri Bholanath Carpets reports standalone net profit of Rs 0.02 crore in the June 2024 quarter
  30-Sep-24   07:34
  Gala Precision Engineering consolidated net profit rises 38.55% in the June 2024 quarter
  30-Sep-24   07:34
  Kross standalone net profit declines 4.25% in the June 2024 quarter
  28-Sep-24   07:36
  Jamna Auto Industries consolidated net profit rises 1.73% in the June 2024 quarter
  28-Sep-24   07:35
  Baazar Style Retail reports standalone net loss of Rs 0.39 crore in the June 2024 quarter
  26-Sep-24   07:35
  Mysore Paper Mills reports standalone net loss of Rs 22.19 crore in the June 2024 quarter
  26-Sep-24   07:35
  Educomp Solutions reports standalone net loss of Rs 1.81 crore in the June 2024 quarter
  25-Sep-24   07:30
  Ecos (India) Mobility & Hospitality consolidated net profit declines 3.08% in the June 2024 quarter
  25-Sep-24   07:30
  Orissa Minerals Development Company reports standalone net loss of Rs 2.08 crore in the June 2024 quarter
  24-Sep-24   07:43
  Apis India consolidated net profit declines 40.92% in the June 2024 quarter
  21-Sep-24   07:30
Back Top